Investor Presentation for the quarter and year ended 31st March, 2026
Pursuant to Regulation 24A of SEBI (LODR) Regulations, 2015, please find enclosed the Annual Secretarial Compliance Report of the Company for the financial year ended March 31, 2026 duly certified by the Practicing Company Secretary.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Purchase of vacant land by the Company
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Appointment of Internal Auditor for FY 2026-27
Please find enclosed the Standalone Audited Financial Results for the FY 2025-26
Please find enclosed the Standalone Audited Financial results for the Quarter and Year ended 31st March, 2026 along with the Auditors Report as approved by the Board of Directors at their meeting held today, 29th May, 2026. Pursuant to Regulation 33(3)(d) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, declaration by the Company with respect to Auditors Report with unmodified opinion is also enclosed.
The Audited financial results of the Company for the quarter and financial year ended 31st March, 2026
Newspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKMC Speciality Hospitals (India) Ltd 2CIN NO.L85110TN1982PLC009781 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 71.35 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Indumathi P Designation: Company Secretary and Compliance Officer EmailId: cs.kmcshil@kauveryhospital.com Name of the Chief Financial Officer: K Anand Babu Designation: Chief Financial Officer EmailId: cfo@kauveryhealthcare.com Date: 17/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Please find enclosed a copy of the certificate dated April 6, 2026 received from our RTA for the quarter ended March 31, 2026.
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 40.84 | 42.32 | 49.12 | 44.89 | 53.07 | 56.23 | 61.36 | 60.93 | 66.55 | 74.90 | 82.06 | 82.25 |
| YOY Revenue Growth % | 16.52% | 6.88% | 22.73% | 9.27% | 29.93% | 32.87% | 24.92% | 35.74% | 25.41% | 33.2% | 33.73% | 34.99% |
| Other Income | 1.64 | 0.57 | 0.58 | 0.77 | 0.62 | 0.46 | 1.21 | 0.79 | 0.80 | 1.24 | 1.13 | 1.91 |
| Total Income | 42.48 | 42.89 | 49.70 | 45.66 | 53.69 | 56.69 | 62.58 | 61.73 | 67.35 | 76.15 | 83.19 | 84.16 |
| Total Expenses + | 33.12 | 33.61 | 37.21 | 36.24 | 46.29 | 51.35 | 52.53 | 52.90 | 57.35 | 61.41 | 64.71 | 64.36 |
| Cost of Materials Consumed | 0.87 | 0.80 | 1.02 | 0.90 | 1.84 | 2.48 | 2.52 | 3.07 | 3.23 | 3.59 | 3.79 | 4.03 |
| Employee Benefit Expense | 9.33 | 8.80 | 10.03 | 10.11 | 12.56 | 12.99 | 13.57 | 12.77 | 15.32 | 16.95 | 17.57 | 15.97 |
| Other Expenses | 15.52 | 16.41 | 18.53 | 16.64 | 20.30 | 22.60 | 22.99 | 23.26 | 24.42 | 26.07 | 28.29 | 28.24 |
| Operating Profit | 7.72 | 8.71 | 11.91 | 8.65 | 6.78 | 4.88 | 8.83 | 8.03 | 9.21 | 13.50 | 17.35 | 17.90 |
| OPM % | 18.9% | 20.6% | 24.3% | 19.3% | 12.8% | 8.7% | 14.4% | 13.2% | 13.8% | 18% | 21.1% | 21.8% |
| Profit Before Tax + | 9.36 | 9.28 | 12.49 | 9.42 | 7.40 | 5.34 | 10.05 | 8.82 | 10.01 | 14.74 | 18.48 | 19.80 |
| Tax Expense | 2.43 | 2.41 | 3.00 | 2.34 | 1.89 | 1.45 | 2.53 | 4.30 | 2.47 | 3.90 | 4.75 | 5.17 |
| Tax % | 25.9% | 26% | 24% | 24.8% | 25.5% | 27.2% | 25.2% | 48.7% | 24.7% | 26.4% | 25.7% | 26.1% |
| Profit After Tax | 6.94 | 6.87 | 9.49 | 7.09 | 5.51 | 3.88 | 7.51 | 4.52 | 7.54 | 10.84 | 13.73 | 14.63 |
| EPS (Basic) | 0.43 | 0.42 | 0.58 | 0.43 | 0.34 | 0.24 | 0.46 | 0.27 | 0.46 | 0.66 | 0.84 | 0.90 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 305.77 | 231.60 | 177.18 | 155.76 | 136.07 | 102.64 |
| YOY Revenue Growth % | 32.03% | 30.72% | 13.75% | 14.47% | 32.58% | - |
| Other Income | 5.08 | 3.09 | 3.56 | 3.13 | 2.15 | 1.93 |
| Total Income | 310.84 | 234.68 | 180.74 | 158.89 | 138.22 | 104.56 |
| Total Expenses + | 247.82 | 203.08 | 140.18 | 122.89 | 106.12 | 86.52 |
| Cost of Materials Consumed | 14.64 | 9.91 | 3.59 | 2.88 | 2.67 | 2.68 |
| Employee Benefit Expense | 65.81 | 51.89 | 38.27 | 31.20 | 27.13 | 21.51 |
| Other Expenses | 107.02 | 89.15 | 67.10 | 60.27 | 51.21 | 41.57 |
| Operating Profit | 57.95 | 28.52 | 37.00 | 32.86 | 29.95 | 16.12 |
| OPM % | 19% | 12.3% | 20.9% | 21.1% | 22% | 15.7% |
| Profit Before Exceptional | 63.02 | 31.60 | 40.56 | 35.99 | 32.10 | 18.04 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | 63.02 | 31.60 | 40.56 | 35.99 | 32.10 | 18.04 |
| Tax Expense | 16.29 | 10.18 | 10.18 | 9.30 | 8.37 | 5.26 |
| Tax % | 25.8% | 32.2% | 25.1% | 25.8% | 26.1% | 29.2% |
| Profit After Tax | 46.73 | 21.43 | 30.38 | 26.69 | 23.73 | 12.78 |
| EPS (Basic) | 2.87 | 1.31 | 1.86 | 1.64 | 1.45 | 0.78 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 250.91 | 252.76 | 230.20 | 128.24 | 86.29 | 78.86 |
| Property, Plant & Equipment | 247.44 | 247.25 | 205.20 | 83.48 | 74.21 | 73.13 |
| Capital Work in Progress | 0.00 | 0.00 | 0.64 | 34.04 | 5.64 | 1.61 |
| Non-Current Investments | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.03 | 0.04 | 0.06 | 0.39 | 0.80 | 0.50 |
| Current Assets + | 81.21 | 33.24 | 33.52 | 53.41 | 42.48 | 26.13 |
| Inventories | 3.88 | 3.50 | 2.05 | 2.27 | 1.87 | 1.75 |
| Trade Receivables | 7.35 | 5.98 | 4.38 | 4.37 | 3.54 | 2.55 |
| Cash and Cash Equivalents | 50.02 | 9.19 | 4.85 | 1.84 | 1.67 | 2.13 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 210.43 | 164.33 | 143.58 | 113.50 | 86.80 | 63.33 |
| Equity Share Capital | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 |
| Other Equity | 194.12 | 148.02 | 127.27 | 97.19 | 70.49 | 47.02 |
| Non-Current Liabilities | 79.02 | 83.73 | 73.68 | 45.61 | 22.45 | 29.11 |
| Current Liabilities | 42.67 | 37.94 | 46.45 | 22.54 | 19.51 | 12.55 |
| Total Liabilities | 121.69 | 121.67 | 120.14 | 68.15 | 41.96 | 41.66 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | 79.10 | 57.58 | 38.42 | 32.33 | 29.12 | 29.71 |
| Cash from Investing Activities | -16.93 | -50.94 | -55.91 | -47.99 | -28.51 | -46.69 |
| Cash from Financing Activities | -21.34 | -2.30 | 20.50 | 15.84 | -1.07 | 17.98 |
| Net Increase/Decrease in Cash | 40.83 | 4.34 | 3.01 | 0.17 | -0.46 | 1.01 |